Alaunos Therapeutics | ZIOP - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Alaunos Therapeutics USD -1.19M 148K 2025-09
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Baxter International USD 66M 280.2M 2026-03
Biogen USD 514.3M 128.8M 2026-03
Bioline Rx USD -2.21M 96K 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Celltrion KRW 13.72B 287.31B 2025-12
Corcept Therapeutics USD -49.6M 54.09M 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Curis USD -7.88M 4.63M 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
Incyte USD 324.17M 59.7M 2026-03
Intrexon USD -60.84M 26.62M 2024-06
Ionis Pharmaceuticals USD -118M 97M 2026-03
J&J USD 6.62B 1.03B 2026-03
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Merck USD -1.88B 8.12B 2026-03
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Novartis USD 4.24B 171M 2026-03
Organigram Holdings CAD -20.13M 7.92M 2025-12
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pfizer USD 4.99B 340M 2026-03
Pharma Mar EUR 622K 42.99M 2026-03
PTC Therapeutics USD 45.89M 127.51M 2026-03
Qiagen NV USD 121.88M 15.41M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sartorius EUR 160.7M 9.5M 2026-03
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
TG Therapeutics USD 34.8M 15.7M 2026-03
Tilray USD -20.01M 9.34M 2025-09
Verastem USD -41.48M 23.2M 2025-12
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03